» Articles » PMID: 30374014

Expression of Micro-RNA-492 (MiR-492) in Human Cervical Cancer Cell Lines is Upregulated by Transfection with Wild-Type P53, Irradiation, and 5-Fluorouracil Treatment In Vitro

Overview
Journal Med Sci Monit
Date 2018 Oct 31
PMID 30374014
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND The status of p53 is critical to the chemoradiosensitivity of cervical cancer cells. Wild-type p53 is essential to orchestrate the cellular response to cytotoxic stimuli. Our previous data illustrated that cervical cancer patients whose specimens overexpressed microR-492 (miR-492) were highly sensitive to concurrent chemoradiation. Although p53 activation has been reported to upregulate miR-492 by a miRNA profiling assay in lung cancer cells, the transcriptional regulation of miR-492 in cervical cancer cells remains poorly understood. Therefore, we aimed to decipher the relationship between p53 and miR-492 in cervical cancer cells. MATERIAL AND METHODS The expression of p53 and miR-492 in cervical cancer cell lines was measured by western blot and real-time PCR. After cells were transfected with wild-type p53 plasmid or were treated by irradiation and 5-fluorouracil (5-FU), the expression changes of p53 as well as miR-492 were examined by western blot and real-time PCR. The putative p53 binding site of miR-492 was first analyzed by bioinformatics tools, then validated by chromatin immunoprecipitation and dual-luciferase reporter assays. RESULTS We found that miR-492 was upregulated in cells with wild-type p53 compared to cells with mutant p53. Transfection of wild-type p53 plasmid or treatments with cytotoxic reagents including irradiation and 5-FU all induced miR-492 overexpression. Bioinformatics analysis and experimental validations further proved p53 interacted with miR-492 promoter directly. CONCLUSIONS In cervical cancer cells, p53 activated miR-492 expression transcriptionally.

Citing Articles

Indisulam exerts anticancer effects via modulation of transcription, translation and alternative splicing on human cervical cancer cells.

Dou Z, Zhang X, Su W, Zhang T, Ye F, Zhao D Am J Cancer Res. 2023; 13(7):2922-2937.

PMID: 37559979 PMC: 10408480.


Circulating miRNAs in Serum as Biomarkers for Early Diagnosis of Non-small Cell Lung Cancer.

Duan X, Qiao S, Li D, Li S, Zheng Z, Wang Q Front Genet. 2021; 12:673926.

PMID: 34306018 PMC: 8299278. DOI: 10.3389/fgene.2021.673926.


Development and validation of a novel circular RNA as an independent prognostic factor in acute myeloid leukemia.

Wang J, Pan J, Huang S, Li F, Huang J, Li X BMC Med. 2021; 19(1):28.

PMID: 33517886 PMC: 7849103. DOI: 10.1186/s12916-020-01898-y.


is a Molecular Regulator of Growth, Invasion, and Epithelial-to-Mesenchymal Transition of Cervical Cancer.

Sun J, Wang S, Liu P, Liu Y Cancer Manag Res. 2020; 12:12723-12733.

PMID: 33328767 PMC: 7735720. DOI: 10.2147/CMAR.S267634.


miR‑34c‑5p targets Notch1 and suppresses the metastasis and invasion of cervical cancer.

Wei H, Wang X, Niu X, Jiao R, Li X, Wang S Mol Med Rep. 2020; 23(2).

PMID: 33300051 PMC: 7751466. DOI: 10.3892/mmr.2020.11759.


References
1.
Ferreira C, Tolis C, Giaccone G . p53 and chemosensitivity. Ann Oncol. 1999; 10(9):1011-21. DOI: 10.1023/a:1008361818480. View

2.
Ishikawa H, Mitsuhashi N, Sakurai H, Maebayashi K, NIIBE H . The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone. Cancer. 2001; 91(1):80-9. DOI: 10.1002/1097-0142(20010101)91:1<80::aid-cncr11>3.0.co;2-e. View

3.
Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

4.
Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba M . PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002; 18(2):333-4. DOI: 10.1093/bioinformatics/18.2.333. View

5.
Hoh J, Jin S, Parrado T, Edington J, Levine A, Ott J . The p53MH algorithm and its application in detecting p53-responsive genes. Proc Natl Acad Sci U S A. 2002; 99(13):8467-72. PMC: 124275. DOI: 10.1073/pnas.132268899. View